Form 4: electroCore Director Boosts Stake with Warrant Exercises

An electroCore director increased their beneficial ownership by exercising warrants to acquire common stock.

Summary

• Thomas J. Errico, a Director at electroCore, Inc. (ECOR), acquired a total of 42,055 shares of common stock through the exercise of warrants on March 19, 2026.
• The first transaction involved the acquisition of 22,803 shares of common stock at an exercise price of $4.35 per share.
• The second transaction involved the acquisition of 19,252 shares of common stock at an exercise price of $6.43 per share.
• Following these transactions, Mr. Errico's total beneficial ownership in electroCore, Inc. increased to 350,071 shares.
• The beneficial ownership includes 259,106 shares owned directly, 1,296 shares held by a family trust, 11,000 shares held by a personal trust, 26,615 unvested deferred stock units (DSUs), and 52,054 vested shares from previously issued DSUs.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as insider buying typically signals management confidence, though the specific impact depends on the overall context of the company's financial health and market conditions.

Positives

• A director's exercise of warrants to acquire common stock demonstrates a direct investment and confidence in the company's future prospects.
• The increase in beneficial ownership by a key insider aligns the director's interests more closely with those of shareholders.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider buying, particularly through warrant exercises, can signal management's belief in the company's valuation and future growth, which is a common indicator observed across various sectors, including the medical device industry where electroCore operates.

Related Party Transactions

• Thomas J. Errico, a Director of electroCore, Inc., acquired common stock through the exercise of warrants, representing a direct transaction between an insider and the company.

Stakeholder Impact

• Shareholders may view this insider buying as a positive indicator of management's belief in the company's value, potentially boosting investor confidence.

Key Dates

Recommendation

While insider buying is a positive signal, a single Form 4 filing typically does not warrant a 'buy' recommendation without broader fundamental analysis. It suggests management confidence, which supports a 'hold' position for existing investors and encourages further due diligence for potential new investors.

Keywords

electroCore, ECOR, Insider Trading, Form 4, Warrant Exercise, Common Stock, Director, Beneficial Ownership, Medical Devices